跳转至内容
Merck
CN

Infantile neuroaxonal dystrophy caused by uniparental disomy.

Developmental medicine and child neurology (2014-03-19)
Joyce Solomons, Oliver Ridgway, Carol Hardy, Manju A Kurian, Manju Kurian, Sandeep Jayawant, Sarah Hughes, Pieter Pretorius, Andrea H Németh
摘要

Infantile neuroaxonal dystrophy (INAD) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the phospholipase A2 group 6 (Pla2G6) gene. Affected individuals usually present between the ages of 6 months and 2 years with rapid cognitive and motor regression and axial hypotonia. Gait disturbance, limb spasticity, cerebellar signs, and optic atrophy are other common features associated with INAD. Although magnetic resonance imaging (MRI) can sometimes contribute towards the diagnosis, the confirmation of INAD is by Pla2G6 gene analysis. In this case report, we describe the first individual (female) with INAD due to a combination of uniparental heterodisomy and isodisomy; we discuss the possible underlying mechanism and highlight the importance of parental carrier testing in accurately predicting the recurrence risk in these families. We also confirm the recent report of hypertrophy of the clava (also known as the 'gracile tubercle') as a useful MRI sign in INAD.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
磷脂酶 A 2 from honey bee venom (Apis mellifera), salt-free, lyophilized powder, 600-2400 units/mg protein
Sigma-Aldrich
磷脂酶 A2 来源于猪胰腺, ammonium sulfate suspension, ≥600 units/mg protein
Sigma-Aldrich
磷脂酶 A 2 来源于牛胰腺, lyophilized powder, ≥20 units/mg protein